The Biotech Growth Trust PLC
BIOG.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | -£0 | £0 | -£0 | -£0 |
| % Growth | -196.4% | 313.4% | 82% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | -£0 | £0 | -£0 | -£0 |
| % Margin | 101.7% | 97.1% | 114.1% | 102.3% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | -£0 |
| Operating Expenses | £0 | £0 | £0 | -£0 |
| Operating Income | -£0 | £0 | -£0 | -£0 |
| % Margin | 106.5% | 95.2% | 97.4% | 95.3% |
| Other Income/Exp. Net | £0 | -£0 | -£0 | £0 |
| Pre-Tax Income | -£0 | £0 | -£0 | -£0 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£0 | £0 | -£0 | -£0 |
| % Margin | 106.7% | 92.8% | 109.7% | 96.5% |
| EPS | -2.62 | 2.07 | -1.03 | -4.88 |
| % Growth | -226.6% | 301% | 78.9% | – |
| EPS Diluted | -2.62 | 2.07 | -1.03 | -4.88 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£0 | £0 | £0 | -£0 |
| % Margin | 106.5% | 0% | -0% | 5.1% |